Last reviewed · How we verify
Cilengitide dose escalation
At a glance
| Generic name | Cilengitide dose escalation |
|---|---|
| Also known as | Cilengitidine |
| Sponsor | Centre Oscar Lambret |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma (PHASE1)
- Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery (PHASE1)
- EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |